阿卡迪亞製藥公司
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership448,549 shares
Latest Disclosed Value $ 9,984,702
UBS Group AG ownership in ACAD / ACADIA Pharmaceuticals Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 448,549 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $9,984,702 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 769,392 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -41.70% during the quarter.

UBS Group AG has a history of taking positions in derivatives of the underlying security (ACAD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:ACAD / ACADIA Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 448,549 -320,843 -41.70 9,985 -51.42 0.0003
2026-01-29 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 769,392 104,546 15.72 20,550 44.85 0.0033
2025-11-13 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 664,846 -71,377 -9.70 14,188 -10.66 0.0022
2025-08-14 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 736,223 -320,627 -30.34 15,880 -9.54 0.0027
2025-05-13 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,056,850 -184,425 -14.86 17,554 -22.93 0.0032
2025-02-14 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,241,275 637,123 105.46 22,777 145.15 0.0042
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 604,152 148,601 32.62 9,292 25.52 0.0020
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 455,551 111,670 32.47 7,403 16.42 0.0018
2024-05-13 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 343,881 36,522 11.88 6,358 -33.93 0.0016
2024-02-09 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 307,359 162,663 112.42 9,623 219.17 0.0029
2023-11-09 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 144,696 4,995 3.58 3,015 -9.87 0.0010
2023-08-11 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 139,701 -13,490 -8.81 3,346 16.02 0.0011
2023-05-12 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 153,191 -214,128 -58.29 2,883 -50.69 0.0011
2023-02-08 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 367,319 316,246 619.20 5,848 600.24 0.0022
2022-11-10 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 51,073 17,271 51.09 835 75.05 0.0004
2022-08-10 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 33,802 -29,631 -46.71 477 -68.97 0.0002
2022-05-16 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 63,433 -155,475 -71.02 1,537 -69.92 0.0005
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 218,908 1,405 0.65 5,109 41.45 0.0015
2021-11-15 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 217,503 205,648 1,734.69 3,612 1,149.83 0.0011
2021-08-13 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 11,855 -15,080 -55.99 289 -58.42 0.0001
2021-05-12 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 26,935 -11,726 -30.33 695 -66.38 0.0002
2021-02-11 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 38,661 8,283 27.27 2,067 64.96 0.0007
2020-11-12 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 30,378 5,951 24.36 1,253 5.83 0.0005
2020-07-31 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 24,427 422 1.76 1,184 16.77 0.0005
2020-05-01 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 24,005 -115,667 -82.81 1,014 -83.03 0.0005
2020-02-14 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 139,672 20,250 16.96 5,975 39.02 0.0021
2019-11-14 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 119,422 60,565 102.90 4,298 173.24 0.0017
2019-08-14 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 58,857 -20,150 -25.50 1,573 -25.87 0.0006
2019-05-14 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 79,007 -226,807 -74.17 2,122 -57.09 0.0009
2019-02-14 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 305,814 -3,860 -1.25 4,945 -23.08 0.0022
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 309,674 131,931 74.23 6,429 136.88 0.0025
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 177,743 -261,344 -59.52 2,714 -72.49 0.0012
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 439,087 221,465 101.77 9,866 50.56 0.0043
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 217,622 -35,213 -13.93 6,553 -31.19 0.0027
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 252,835 7,955 3.25 9,524 39.44 0.0044
2017-11-14 2017-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 244,880 165,503 208.50 6,830 150.27 0.0035
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 244,880 165,503 6,830
2017-11-14 2017-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 79,377 -104,105 -56.74 2,729 -48.42 0.0015
2017-05-12 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 79,377 -104,105 2,729
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 183,482 25,472 16.12 5,291 5.27 0.0029
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 158,010 -29,577 -15.77 5,026 -17.46 0.0030
2016-08-12 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 187,587 170,485 996.87 6,089 1,171.19 0.0038
2016-05-12 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 17,102 4,158 32.12 479 3.90 0.0003
2016-02-16 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 12,944 -40,084 -75.59 461 -73.72 0.0003
2015-11-13 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 53,028 35,413 201.04 1,754 137.67 0.0012
2015-08-14 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 17,615 2,511 16.62 738 50.00 0.0005
2015-05-14 2015-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 15,104 -23,617 -60.99 492 -59.97 0.0003
2015-02-17 2014-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 38,721 38,721 1,229 0.0009
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-12 2020-09-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-31 2020-06-30 13F ACADIA PHARMACEUTICALS COM Call 29,200 1,415 n/a n/a n/a
2020-05-01 2020-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ACADIA PHARMACEUTICALS COM Call 47,000 2,011 n/a n/a n/a
2016-05-12 2016-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F ACADIA PHARMACEUTICALS COM Call 2,900 0.00 103 7.29 n/a n/a n/a
2015-11-13 2015-09-30 13F ACADIA PHARMACEUTICALS COM Call 2,900 -12.12 96 -30.43 n/a n/a n/a
2015-08-14 2015-06-30 13F ACADIA PHARMACEUTICALS COM Call 3,300 -90.15 138 -87.36 n/a n/a n/a
2015-05-14 2015-03-31 13F ACADIA PHARMACEUTICALS COM Call 33,500 -54.61 1,092 -53.39 n/a n/a n/a
2015-02-17 2014-12-31 13F ACADIA PHARMACEUTICALS COM Call 73,800 2,343 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-16 2022-03-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM Put 9,000 0.00 210 40.94 n/a n/a n/a
2021-11-15 2021-09-30 13F ACADIA PHARMACEUTICALS COM Put 9,000 0.00 149 -32.27 n/a n/a n/a
2021-08-13 2021-06-30 13F ACADIA PHARMACEUTICALS COM Put 9,000 0.00 220 -5.17 n/a n/a n/a
2021-05-12 2021-03-31 13F ACADIA PHARMACEUTICALS COM Put 9,000 232 n/a n/a n/a
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM Put 1,600 48 n/a n/a n/a
2015-08-14 2015-06-30 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-14 2015-03-31 13F ACADIA PHARMACEUTICALS COM Put 100 -90.91 3 -91.43 n/a n/a n/a
2015-02-17 2014-12-31 13F ACADIA PHARMACEUTICALS COM Put 1,100 35 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.